Drug Policy: Assessing Treatment Expansion Efforts and Drug Control Strategies and Programs, Statement of Triana Mcneil, Acting Director, Homeland Security and Justice and Mary Denigan-Macauley, Acting Director, Health Care, Testimony Before the Committee on Oversight and Reform, House of Representatives [open pdf - 57KB]
From the Document: "This statement includes information from GAO's [Government Accountability Office] 2016 and 2017 reports on access to MAT[medication-assisted treatment] for opioid use disorder, including selected recommendation updates as of May 2019. It also includes information from GAO's March 2019 testimony with preliminary observations on the 2019 National Drug Control Strategy and on GAO's ongoing work regarding ONDCP's [Office of National Drug Control Policy] efforts. For recommendation updates, GAO reviewed HHS [Department of Health and Human Services] documents and spoke with HHS about its recent efforts."
Government Accountability Office: http://www.gao.gov/